Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cardiac amyloidosis.

Neil Maredia1, Simon G Ray

  • 1Specialist Registrar in Cardiology, James Cook University Hospital, Middlesbrough. neilmaredia@hotmail.com

Clinical Medicine (London, England)
|November 5, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Diagnostic and prognostic comparison of stress electrocardiogram, cardiovascular magnetic resonance, and single photon emission computed tomography, alone and sequentially, in stable chest pain.

Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance·2025
Same author

Clinical impact of cardiac magnetic resonance imaging in myocardial infarction with non-obstructive coronary arteries: a prospective multicentre cohort study.

Heart (British Cardiac Society)·2025
Same author

Development and validation of the Aortic valve Stenosis Guarded by Amplified Risk Determination (ASGARD) risk score for safe monitoring in asymptomatic non-severe aortic valve stenosis.

European journal of preventive cardiology·2024
Same author

Association of high-sensitivity troponin T with outcomes in asymptomatic non-severe aortic stenosis: a post-hoc substudy of the SEAS trial.

EClinicalMedicine·2023
Same author

A Noncontrast CMR Risk Score for Long-Term Risk Stratification in Reperfused ST-Segment Elevation Myocardial Infarction.

JACC. Cardiovascular imaging·2022
Same author

Association of Annual N-Terminal Pro-Brain Natriuretic Peptide Measurements With Clinical Events in Patients With Asymptomatic Nonsevere Aortic Stenosis: A Post Hoc Substudy of the SEAS Trial.

JAMA cardiology·2022
Same journal

Resident doctor workforce wellbeing worldwide: lessons between the United Kingdom and Australia.

Clinical medicine (London, England)·2026
Same journal

Premature ventricular complexes.

Clinical medicine (London, England)·2026
Same journal

Heart failure with preserved ejection fraction (HFpEF): diagnosis and management for the general physician.

Clinical medicine (London, England)·2026
Same journal

Trends and Widening Inequities in Cardiovascular-Kidney-Metabolic Involvement in Cardiovascular Mortality: A National Spatiotemporal Analysis, 2014-2023.

Clinical medicine (London, England)·2026
Same journal

Educating current and future healthcare professionals on evidence-based sustainable medicine.

Clinical medicine (London, England)·2026
Same journal

UK Foundation Programme training needs a national minimum standard for advanced life support.

Clinical medicine (London, England)·2026
See all related articles

Systemic amyloidosis frequently impacts the heart, presenting initial symptoms like cardiac failure. Early diagnosis via imaging and biomarkers is crucial, though treatment outcomes for cardiac amyloidosis remain challenging.

Area of Science:

  • Cardiology
  • Hematology
  • Oncology

Background:

  • Systemic amyloidosis often manifests cardiac involvement, with symptoms like heart failure and arrhythmias being primary indicators.
  • Cardiac amyloidosis, a serious complication, necessitates timely diagnosis and management strategies.

Observation:

  • Two case studies highlight the diagnostic approaches for cardiac amyloidosis, utilizing echocardiography, magnetic resonance imaging, and serum N-terminal probrain natriuretic peptide (NT-proBNP).
  • Clinical manifestations primarily include cardiac failure and rhythm disturbances due to amyloid deposition.

Findings:

  • Diagnostic tools like echocardiography and MRI are effective in identifying cardiac involvement.
  • While chemotherapy and transplantation offer potential treatment avenues, their results are variable, and stem-cell transplantation carries significant mortality risks in cardiac cases.

Related Experiment Videos

Implications:

  • Emerging therapies show promise, but the prognosis for cardiac amyloidosis remains guarded.
  • Further research into novel therapeutic agents and treatment protocols is essential to improve patient outcomes.